AIRDOC-B has recently entered into a strategic partnership with Zhuhai Quanyi Technology Co., Ltd., a leading nationwide primary care internet medical platform operator. The collaboration will integrate retinal imaging AI technology with primary healthcare resources through joint operations, focusing on chronic disease early screening and health management services in primary care settings to address uneven medical resource distribution and achieve AI healthcare accessibility for all.

**Complementary Strengths: Technology and Resources Drive Dual Growth**

This partnership represents a powerful alliance between medical AI technology and internet healthcare platforms. As a global leader in retinal imaging artificial intelligence, AIRDOC-B will leverage its core technological advantages in retinal imaging AI to provide cutting-edge artificial intelligence-assisted diagnostic solutions for fundus diseases and chronic conditions. Combined with Zhuhai Quanyi's extensive network of primary healthcare institutions nationwide and internet hospital platform, both parties will work together to bridge the "last mile" of AI healthcare accessibility, accelerating the application of retinal imaging AI technology in county-level medical facilities and community clinics.

**Empowering Primary Care: AI Fundus Examination Makes Healthcare Accessible Everywhere**

Currently, Zhuhai Quanyi's fundus AI business has begun joint operations with AIRDOC-B. Moving forward, AIRDOC-B will fully support Zhuhai Quanyi's existing network of hundreds of primary healthcare institution clients, providing terminal clinics with advanced integrated software-hardware retinal imaging AI diagnostic solutions plus remote expert support as a comprehensive one-stop service. This will bring tertiary hospital-level fundus diagnostic capabilities to county and community levels, enabling patients to conveniently and quickly understand their chronic disease conditions through AI diagnosis at primary care facilities and receive electronic health reports. This initiative will help improve the referral system while enhancing primary care physicians' diagnostic capabilities for eye diseases and chronic disease prevention and control.

Furthermore, leveraging Zhuhai Quanyi's internet hospital platform, patients can access online follow-up consultations, remote prescriptions, and continuous health management services, ultimately supporting the national "Healthy China 2030" goal of household chronic disease management.

This collaboration holds profound significance for both AIRDOC-B and Quanyi in terms of technological cooperation and operational model exploration. AIRDOC-B spokesperson Zhang Dalei stated: "Zhuhai Quanyi's commitment to primary healthcare accessibility aligns perfectly with AIRDOC-B's vision of making health accessible everywhere through AI products. We hope AI medical technology will empower primary care to make quality healthcare more efficient." A Zhuhai Quanyi representative noted: "With AIRDOC-B's leading AI technology, our primary healthcare network will achieve service capability upgrades, providing an innovative model for the Healthy China strategy."

Looking ahead, AIRDOC-B will continue to fulfill its mission of "making health accessible everywhere." The company will persist in exploring innovation in the medical AI field, partnering with more industry collaborators to build a broader medical AI ecosystem network, jointly promoting equitable access to quality medical resources across all corners of society and contributing stronger AI capabilities to global healthcare development.